Summaries & Associations of Study Results
TR-005 Proflavin hydrochloride
Target Organs and Levels of Evidence
NTP Technical Report Number 005
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| PROFLAVIN HYDROCHLORIDE 952-23-8 |
03/25/77 | BACTERIOSTATIC, TREATMENT OF PSORIASIS AND TYPE - II HERPES VIRUS INFECTIONS. | Dosed-Feed R: 0,300,600, M: 0,200,400 PPM/50 PER GROUP | DOW |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: EQUIVOCAL | INTESTINES (LEIOMYOSARCOMA) | |||
| FR: NEGATIVE | ||||
| MM: EQUIVOCAL | LIVER (CARCINOMA) | |||
| FM: EQUIVOCAL | LIVER (CARCINOMA) | |||
Web page last updated on February 10, 2006
